You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

TRIMETH Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Trimeth, and what generic alternatives are available?

Trimeth is a drug marketed by Alpharma Us Pharms, Naska, Avet Lifesciences, Lupin, Sun Pharm Industries, Am Regent, Hospira, Smith And Nephew, Solopak, Watson Labs, Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Teva, Bausch And Lomb, Epic Pharma Llc, Sandoz, and Somerset Theraps Llc. and is included in twenty-five NDAs.

The generic ingredient in TRIMETH is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIMETH?
  • What are the global sales for TRIMETH?
  • What is Average Wholesale Price for TRIMETH?
Summary for TRIMETH
US Patents:0
Applicants:18
NDAs:25
Drug Prices: Drug price information for TRIMETH
DailyMed Link:TRIMETH at DailyMed
Drug patent expirations by year for TRIMETH
Drug Prices for TRIMETH

See drug prices for TRIMETH

US Patents and Regulatory Information for TRIMETH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIMETH/SULFA sulfamethoxazole; trimethoprim SUSPENSION;ORAL 072289-001 May 23, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries TRIMETHOPRIM trimethoprim TABLET;ORAL 070494-001 Jan 22, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064211-001 Apr 13, 1998 AT RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 091330-001 Mar 8, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.